Search research articles
Contact Us
Filters
Showing results (1-10 of 73) with videos related to
Page
of 8
Sort By:
Lipids in Health and Disease
|
November 18, 2011
Low incidence of paradoxical reductions in HDL-C levels in dyslipidemic patients treated with fenofibrate alone or in combination with ezetimibe or ezetimibe/simvastatin
Michel Farnier, Qian Dong, Arvind Shah, et al.
Vascular Health and Risk Management
|
May 24, 2014
Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia
Michel Farnier, Erluo Chen, Amy O Johnson-Levonas, et al.
Clinical Therapeutics
|
December 26, 2007
Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques
Leiv Ose, Robert Reyes, Amy O Johnson-Levonas, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male
|
January 12, 2010
Increased occurrence of marked elevations of lipoprotein(a) in ageing, hypercholesterolaemic men with low testosterone
Steven A Kaplan, Jianxin Lin, Amy O Johnson-Levonas, et al.
Journal of Clinical Lipidology
|
June 5, 2012
Effects of coadministered extended-release niacin/laropiprant and simvastatin on lipoprotein subclasses in patients with dyslipidemia
Christie Ballantyne, Gilbert Gleim, Nancy Liu, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male
|
December 17, 2009
Elevated high sensitivity C-reactive protein levels in aging men with low testosterone
Steven A Kaplan, Amy O Johnson-Levonas, Jianxin Lin, et al.
Journal of Clinical Lipidology
|
February 12, 2015
Changes in LDL particle concentrations after treatment with the cholesteryl ester transfer protein inhibitor anacetrapib alone or in combination with atorvastatin
Ronald M Krauss, Cathy Anne Pinto, Yang Liu, et al.
Atherosclerosis
|
July 25, 2013
Effects of ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non-HDL cholesterol in patients with primary hypercholesterolemia
Michel Farnier, John R Guyton, Erin Jensen, et al.
Clinical Pharmacology in Drug Development
|
April 30, 2016
Evaluation of potential for pharmacokinetic interaction between mometasone furoate and formoterol fumarate after oral inhalation from a fixed-dose combination metered-dose inhaler device
Teddy Kosoglou, James Hubbell, Amy O Johnson-Levonas, et al.
Journal of Clinical Pharmacology
|
September 29, 2009
Multiple doses of sitagliptin, a selective DPP-4 inhibitor, do not meaningfully alter pharmacokinetics and pharmacodynamics of warfarin
D Hamish Wright, Gary A Herman, Andrea Maes, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 73) with videos related to
Sort By:
Page
of 8
Lipids in Health and Disease
|
November 18, 2011
Low incidence of paradoxical reductions in HDL-C levels in dyslipidemic patients treated with fenofibrate alone or in combination with ezetimibe or ezetimibe/simvastatin
Michel Farnier, Qian Dong, Arvind Shah, et al.
Vascular Health and Risk Management
|
May 24, 2014
Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia
Michel Farnier, Erluo Chen, Amy O Johnson-Levonas, et al.
Clinical Therapeutics
|
December 26, 2007
Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques
Leiv Ose, Robert Reyes, Amy O Johnson-Levonas, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male
|
January 12, 2010
Increased occurrence of marked elevations of lipoprotein(a) in ageing, hypercholesterolaemic men with low testosterone
Steven A Kaplan, Jianxin Lin, Amy O Johnson-Levonas, et al.
Journal of Clinical Lipidology
|
June 5, 2012
Effects of coadministered extended-release niacin/laropiprant and simvastatin on lipoprotein subclasses in patients with dyslipidemia
Christie Ballantyne, Gilbert Gleim, Nancy Liu, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male
|
December 17, 2009
Elevated high sensitivity C-reactive protein levels in aging men with low testosterone
Steven A Kaplan, Amy O Johnson-Levonas, Jianxin Lin, et al.
Journal of Clinical Lipidology
|
February 12, 2015
Changes in LDL particle concentrations after treatment with the cholesteryl ester transfer protein inhibitor anacetrapib alone or in combination with atorvastatin
Ronald M Krauss, Cathy Anne Pinto, Yang Liu, et al.
Atherosclerosis
|
July 25, 2013
Effects of ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non-HDL cholesterol in patients with primary hypercholesterolemia
Michel Farnier, John R Guyton, Erin Jensen, et al.
Clinical Pharmacology in Drug Development
|
April 30, 2016
Evaluation of potential for pharmacokinetic interaction between mometasone furoate and formoterol fumarate after oral inhalation from a fixed-dose combination metered-dose inhaler device
Teddy Kosoglou, James Hubbell, Amy O Johnson-Levonas, et al.
Journal of Clinical Pharmacology
|
September 29, 2009
Multiple doses of sitagliptin, a selective DPP-4 inhibitor, do not meaningfully alter pharmacokinetics and pharmacodynamics of warfarin
D Hamish Wright, Gary A Herman, Andrea Maes, et al.
Page
of 8